跳至主要内容
临床试验/NCT02355080
NCT02355080已完成2 期

A Bundled Rapid HIV/HCV Testing Intervention to Increase Receipt of Test Results

Columbia University1 个研究点 分布在 1 个国家目标入组 134 人开始时间: 2016年4月最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
已完成
入组人数
134
试验地点
1
主要终点
Self-Report Receipt of HIV and Hepatitis C Test Results

研究概览

简要总结

This is a randomized controlled clinical trial in which adults receiving drug abuse treatment will be recruited to participate in a HIV and hepatitis C (HCV) testing study. The purpose of this study is to test the efficacy of two HIV/HCV testing strategies on increasing receipt of test results: (1) on-site bundled rapid HIV/HCV testing (i.e., joint offer of HIV and HCV at the point of encounter), and (2) standard of care for HIV and HCV testing.

详细描述

This is a randomized controlled clinical trial in which adults receiving drug abuse treatment will be recruited to participate in a HIV and hepatitis C (HCV) testing study. The purpose of this study is to test the efficacy of two HIV/HCV testing strategies on increasing receipt of test results: (1) on-site bundled rapid HIV/HCV testing (i.e., joint offer of HIV and HCV at the point of encounter), and (2) standard of care for HIV and HCV testing. Secondary outcomes include linkage to care and HIV and HCV risk behaviors. Participants will complete a baseline assessment to report their demographics, sexual risk behaviors, drug-using risk behaviors, utilization of drug abuse treatment services and will be randomized to one of two groups. At one-month post-randomization, participants will complete a follow-up assessment to determine whether or not they received their HIV or HCV test results. At three months post-randomization, participants will complete a follow-up assessment to assess linkage to care and changes, if any, in their HIV and HCV sexual risk behaviors.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Report being HIV and HCV negative, or report not knowing HIV and HCV status
  • Not have received results of an HIV or HCV test initiated within the last 12 months
  • Able and willing to provide informed consent
  • Seeking or currently receiving drug (excluding alcohol only treatment) abuse treatment services at the participating treatment programs
  • At least 18 years old
  • Able to communicate in English
  • Willing to sign a release form that will allow medical record review (to corroborate self-reports of receipt of test results)
  • Able and willing to provide locator information (contact number and address) for follow-up surveys

排除标准

  • 未提供

研究组 & 干预措施

On-site bundled rapid HIV/HCV testing

Experimental

Participants will receive the on-site bundled rapid HIV/HCV testing intervention. In the intervention group, all patients will receive an offer to participate in rapid HIV/HCV testing. Those who accept this offer will: receive pre-test information about testing procedures and education, be tested, receive results during the same visit as testing, and be provided post-test counseling and support services by trained test counselors. Patients with a preliminary positive (i.e., reactive) HIV and/or HCV test result(s) will be actively linked immediately to a health care provider for further evaluation and confirmatory HIV and/or HCV RNA testing.

干预措施: On-site bundled rapid HIV/HCV testing (Behavioral)

Standard of care (SOC)

Active Comparator

Participants will receive the standard of care (SOC) at the study sites. The SOC entails venipuncture whole blood HIV testing + venipuncture whole blood HCV testing. Blood draws are sent to an external laboratory for processing, and patients must return for test results in another visit. Patients may not receive pre-test information or results and post-test counseling, especially if non-reactive or negative test result(s). Reflex testing is not standard practice, therefore some patients may require another visit and blood draw for confirmatory HIV and/or HCV RNA testing. Linkage to care in the SOC is accomplished by referral to a health care provider, either within the participating substance use disorder treatment organization or passive referral to other health facilities.

干预措施: Standard of care (SOC) (Behavioral)

结局指标

主要结局

Self-Report Receipt of HIV and Hepatitis C Test Results

时间窗: One month post-randomization

The primary outcome is self-reported receipt of HIV/HCV test results. This will be measured at one-month post-randomization for all participants. We acknowledge that there are several potential HIV/HCV testing behaviors that could be evaluated in this study: acceptance of testing, completion of testing, and receipt of testing results, either HIV or HCV. Acceptance of testing measures whether or not a participant would accept the offer of an HIV or HCV test. Completion of testing measures whether or not a participant completes the HIV or HCV test. Receipt of test results refers to whether or not a participant self-reports having received the results of the HIV or HCV test.

次要结局

  • Sexual risk behaviors (Counts of unprotected vaginal and anal sex acts in the past 3 months with any sex partner.)(One month post-randomization)
  • Linkage to care (Proportion of patients who initiated HIV/HCV care before the 3-month follow-up among those whose test results were positive for HIV and/or HCV.)(One month post-randomization)
  • Drug use behaviors (Prevalence of use of any drugs in the past 3 months; and unsafe injection practices.)(One month post-randomization)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jemima Frimpong

Assistant Professor of Health Policy and Management

Columbia University

研究点 (1)

Loading locations...

相似试验

A Bundled Rapid HIV/HCV Testing Intervention to... | 临床试验